Nickan Research Institute is a non-profitable research institute dedicated, to research projects in the field of renal pathology/nephrology, especially in the field of renal protection. The main aim of this research institute is searching for novel ways in medicine, particularly for kidney injury prevention and treatment. This institute has also a publishing center which publishes books and journals such as “Journal of Renal Injury Prevention", mostly in its field of research aims. Nickan Research Institute is an Open Access publisher, founded in 2012. When publishing in any of Nickan Research Institute’s journals, authors retain the copyright of their article, which is freely distributed under the Creative Commons Attribution License, permitting the unrestricted use, distribution, and reproduction of the article in any medium, provided the original work is properly cited. Nickan Research Institute serves the worldwide academic communities and contributes to the progress and application of science, by delivering superior scientific publications and scientific information solution provider that enable advancement in scientific research. More than 50 professional editorial board members and international reviewers support our publishing activities.


Where and how is Nickan Research Institute Registered?
Nickan Research Institute, is a registered corporation in Isfahan, Iran. It was first registered on 2012-01-12. The registration number: 3191, Isfahan, Iran. Identity Number: 10260645926, Iran

Place of Public Relation: Nickan Research Institute, No 8, 23 Lane, Farabi North Street, Freiburg Avenue. Isfahan, Iran. Postal Code: 81687-95341, Post Box: 81655-963.
Tel: +98 311 669 2609, Fax: +98 311 669 2517

 


 
The  Chairman of Nickan Research Institute is Professor Hamid Nasri, clinical Nephropathologist.
Department of Nephrology, Division of Nephropathology, Nour Medical, Educational & Therapeutic Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Phone: +98 311 669 2609

Fax: +98 311 669 2517,

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., CC:This email address is being protected from spambots. You need JavaScript enabled to view it.

 



The Vice-Chairman of Nickan Research Institute is Professor Mahmoud Rafieian-Kopaei, Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 


 

Section editor of transplant immunology is Professor Mohammad-Reza Ardalan, Professor of Nephrology and medicine, Fellowship of Transplantation Immunology-Mario -Negri institute of pharmacological research. Director of chronic Kidney Disease Research Center- Tabriz University of Medical Sciences .Tabriz-Iran.

http://ckdrc.tbzmed.ac.ir

 


 

Deputy Editor and Renal pathology scientific division

Professor Muhammed Mubarak
MBBS, DCP (London), MCPS, FCPS
Professor of Pathology,
Histopathology Department,
Sindh Institute of Urology and Transplantation (SIUT),
Karachi, Pakistan

 


 

CONSULTANT

Farhad Shokraneh, Trials Search Coordinator (TSC), Cochrane Schizophrenia Group, The Institute of Mental Health, The University of Nottingham, Nottingham, UK

 

 

Search to Nickan website

Site Traffic

Today33
Yesterday53
This week321
This month803
Total127568

Sunday, 17 December 2017 17:24

The theme of World Hypertension Day 2014: Know your Blood Pressure

Firstly World Hypertension Day inaugurated in May 2005 and has become an annual event ever since. The aim of the World Hypertension Day is to promote public alertness of high blood pressure and to promote citizens of all countries to prevent and control this silent killer, the modern epidemic.World Hypertension Day was initiated firstly by the World Hypertension League.High blood pressure (hypertension) is considered as the silent killer since it has no apparent symptoms. Investigations show that the disease involves more than 1.5 billion people global, and around seven million people die every year from hypertension. 

Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD)

The definition of CKD-MBD is different than the previously recognized as "renal osteodystrophy", and it refers to a systemic disorder of mineral and bone metabolism due to CKD manifested by either one or a combination of the following:
•Abnormalities of calcium, phosphorus, parathyroid hormone (PTH), or vitamin D metabolism.
•Abnormalities in bone turnover, mineralization, volume, linear growth, or strenght.
•Vascular or other soft-tissue calcification.
The term "renal osteodystrophy" is now limited to an alteration of bone morphology in patients with CKD, and it is one measure of the skeletal component of the systemic disorder of CKD-MBD that is quantifiable by histomorphometry of bone biopsy.

 

World Kidney Day 2014:chronic kidney disease and aging

World Kidney Day (WKD) is a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF).Seven years on from the first campaign, World Kidney Day (WKD) has turned into a global phenomenon. On March 13, 2014, medical professionals, government officials, the general public, celebrities and patients will take action locally.
Implication for health policy/practice/research/medical education
In 2014 World Kidney Day (WKD) will focus on chronic kidney disease and aging.The mission of WKD is to raise awareness so that everyone cares for their kidneys and, if appropriate, check to assess if they are at risk for kidney disease. Prevention of kidney disease, early detection, and subsequent kidney protection are critical aims for World Kidney Day.
Our research group is working on the below projects
1-Oxford classification in Iranian IgA nephropathy patients [Renal pathology unite of Dr. Baradaranlaboratory, Isfahan, Iran].
2- Significance of C4d deposits in IgA nephropathy [Renal pathology unite of Dr. Baradaran laboratory, Isfahan, Iran].
3-Renal tubular cell protection by herbal anti-oxidants [Medical Plants Research Center; Shahrekord University of Medical Sciences, Shahrekord, Iran]
4-R229Q Polymorphism of NPHS2 Gene in Patients with Late-Onset Steroid-Resistance Nephrotic Syndrome [Chronic Kidney Disease Research Center; Tabriz University of Medical Sciences,Tabriz, Iran]

Recently Published Papers
Baradaran A. Antiphospholipid syndrome-associated nephropathy; a nephropathy needs classification. J Nephropharmacol. 2012; 1(1):7-9.
Implication for health policy/practice/research/medical education
A suggested classification for antiphospholipid syndrome-associated nephropathy, should be simple and practical. However, the suggestion of a new classification for antiphospholipid syndrome-associated nephropathy will involve a magnificent amount of work and will necessitate a working group, hence, more studies on this topic is suggested.

Nasri H. Antiphospholipid syndrome-associated nephropathy: Current concepts . J Ren Inj Prev 2013; 2(1): 1-2.
Implication for health policy/practice/research/medical education
Renal pathologists and nephrologists should be aware of the morphologic characteristics of APS-nephropathy when they reviewbiopsies of lupus nephropathy patients, especially those with positive antiphospholipid antibodies.

Mubarak M, Nasri H.What nephrolopathologists needto know about antiphospholipid syndrome-associated nephropathy: Is it time for formulating a classification for renal morphologic lesions? J Nephropathology. 2014; 3(1): 4-8.
Implication for health policy/practice/research/medical education
There is sufficient epidemiological, clinical and histopathological evidence to show that antiphospholipid syndrome-associated nephropathy is a distinctive lesion caused by antiphospholipid antibodies in patients with different forms of antiphospholipid syndrome. It is now time to devise a classification for an accurate diagnosis and prognostication of the disease.